Last reviewed · How we verify
NCT05785364
A Post Market Surveillance Study About the MONOCER Cup
trial testing Mpact 3D metal MONOCER cup in Total Hip Arthroplasty in 250 participants. Currently enrolling.
1 February 2050
Quick facts
| Lead sponsor | Medacta International SA |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 250 |
| Start date | 25 January 2022 |
| Primary completion | 1 February 2050 |
| Estimated completion | 1 February 2050 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Mpact 3D metal MONOCER cup
Conditions studied
- Total Hip Arthroplasty — all drugs for Total Hip Arthroplasty →
Sponsor
Medacta International SA — full company profile →
Who can join
Adults 18 to 75, any sex, with Total Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Over the years, the use of large diameter femoral heads has become increasingly common in orthopaedics due to the decreased risk of dislocation due to increased jumping distance and range of motion. The history of total hip arthroplasty does not favour large diameter heads, especially as conventional polyethylene has a high risk of wear. The development of hard-on-hard bearings (CoC) with a second generation ceramic material and the introduction of cross-linked PE have led to the reintroduction of this concept. The Mpact 3D Metal MonoCER cup was developed to offer the advantages of accommodating large diameter heads with an external metal cup with a pre-assembled system that avoids the surgical step of insert-cotile coupling.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05785364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Total Hip Arthroplasty
Currently open trials in the same condition.
- NCT07410000 — Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty · NA · recruiting
- NCT07227064 — Methadone in THA for Post-op Pain and Opioid Reduction · Phase 3 · recruiting
- NCT06768580 — Effect of Oral Melatonin Versus Intraoperative Lidocaine Infusion on Incidence of Postoperative Delirium in Elderly Pati · NA · recruiting
- NCT06904703 — Pericapsular Nerve Group and Lumbar Erector Spinae Plane Blocks for Geriatrics Undergoing Total Hip Arthroplasty · NA · recruiting
- NCT06356116 — Rehabilitation After Direct Anterior Approach for Total Hip Arthroplasty · NA · recruiting
Other Medacta International SA trials
Trials by the same sponsor.
- NCT06775704 — Clinical and Radiological Outcomes of the ROMAX Hip Resurfacing System · recruiting
- NCT06640764 — Multicentre SMS Study - FR · recruiting
- NCT06578897 — A Post-Market, Retrospective Study on 3D Metal Tibial and Femoral Cones · completed
- NCT05679232 — Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty · NA · recruiting
- NCT05062252 — Mirror Medacta Shoulder System Pivotal Trial · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05785364 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medacta International SA
- Last refreshed: 1 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05785364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing